clindamycin has been researched along with Carcinoma, Ductal, Breast in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hawryluk, EB; LeBoeuf, NR; Litsas, G; Sheu, J; Thakuria, M | 1 |
1 other study(ies) available for clindamycin and Carcinoma, Ductal, Breast
| Article | Year |
|---|---|
Papulopustular acneiform eruptions resulting from trastuzumab, a HER2 inhibitor.
Topics: Acneiform Eruptions; Administration, Topical; Adult; Antibodies, Monoclonal, Humanized; Benzoyl Peroxide; Breast Neoplasms; Carcinoma, Ductal, Breast; Clindamycin; Drug Eruptions; Female; Humans; Middle Aged; Minocycline; Receptor, ErbB-2; Trastuzumab | 2015 |